Please Wait.....
Report
Asia Pacific Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others), By Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
Market Report I 2023-10-26 I 225 Pages I The Insight Partners
The Asia Pacific immunodiagnostics market is expected to grow from US$ 2,409.90 million in 2023 to US$ 4,252.35 million by 2030. It is estimated to grow at a CAGR of 8.5% from 2023 to 2030.
Technological Advancements in Immunodiagnostics Drive Asia Pacific Industrial Robotics Market
The current trend in immunodiagnostics is microfluidics and magnetic beads with potential commercialization. These sensitive, specific, and time-saving methodologies are essential in understanding and diagnosing health conditions, such as infectious diseases, metabolic disorders, and cardiac problems.
The increasing applications of immunodiagnostics solutions encouraged the development of targeted treatments and therapies for precision health. The prominent market players also promote assay technologies, microfluidics, and magnetic beads. For immunoassays, magnetic particles, such as Sera-Mag beads, offer a convenient alternative to plate-based ELISAs, as both rely on the same assay principle. Merck KGaA launched the Magna Chip Protein A magnetic beads. This recombinant Protein A is covalently bound to magnetic beads for chromatin immunoprecipitations (Chip assays), providing users with a faster, reproducible, and more efficient reagent for collecting immunocomplexes than agarose beads.
In microfluidics, some immunodiagnostics target single biomarkers. However, a recent trend shows the detection of multiple analytes according to the complexity and the need to make early reliable diagnoses.
In September 2023, Siemens Healthineers released its new CE-marked SARS-CoV-2/FluA/FluB/HRSV assay, a PCR test, and the CLINITEST Rapid COVID-19 + Influenza Antigen Test. The new FTD SARS-CoV-2/FluA/FluB/HRSV assay enables comprehensive and semi-automated molecular testing for seasonal respiratory pathogens. The combination PCR test detects and differentiates clinically relevant viruses such as SARS-CoV-2, Influenza A, Influenza B, and HRSV A/B.
Asia Pacific Immunodiagnostics Market Overview
According to Statista, a large chunk of the Chinese population was suffering from chronic diseases in 2020. Almost 80% of deaths among people aged 60 years in the country are caused due to chronic NCDs, of which the most severe are ischemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), and Type II diabetes. According to China Blueprint, immunological diagnosis has exceeded biochemical diagnosis (accounting for 27%), and the in vitro diagnostics (IVD) market has gone mainstream in China. However, compared to developed countries, there is still room for alternative biochemical diagnosis to expand in China's immunodiagnostics market, as the average ratio of biochemical to immunization diagnosis is about 1:2, according to statistical data from several agencies. As technological innovation advances with the growing need for high-end testing, diagnostics is expected to consolidate its mainstream status.
Furthermore, collaborations between organizations are increasing for developing and producing assays. For instance, in December 2023, Ortho Clinical Diagnostics Trading and Shanghai Medconn Biotechnology signed an agreement as part of a joint venture to develop and manufacture assays for the VITROS immunodiagnostics platform in China. The expertise of Ortho Clinical Diagnostics Trading in developing and designing in vitro diagnostics (IVD) technologies for POC settings, clinical labs, and transfusion medicine will propel the growth of the Asia Pacific immunodiagnostics market in the coming years.
Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Immunodiagnostics Market Segmentation
The Asia Pacific immunodiagnostics market is segmented into product, clinical indication, end user, and country.
Based on product, the Asia Pacific immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered a largest share in the Asia Pacific immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.
Based on clinical indication, the Asia Pacific immunodiagnostics market is segmented into infectious diseases, hepatitis HIV, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered a largest share in the Asia Pacific immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.
Based on end user, the Asia Pacific immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered a largest share in the Asia Pacific immunodiagnostics market.
Based on country, the Asia Pacific immunodiagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. In 2023, China registered a largest share in the Asia Pacific immunodiagnostics market.
Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific immunodiagnostics market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Immunodiagnostics Market - by Product
1.3.2 Asia Pacific Immunodiagnostics Market - by Clinical Indication
1.3.3 Asia Pacific Immunodiagnostics Market - by End User
1.3.4 Asia Pacific Immunodiagnostics Market - by Country
2. Asia Pacific Immunodiagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Immunodiagnostics Market - Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert's Opinion
5. Asia Pacific Immunodiagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market - Asia Pacific Analysis
6.1 Asia Pacific Immunodiagnostics Market Revenue Forecast and Analysis
7. Asia Pacific Immunodiagnostics Market Analysis - by Product
7.1 Overview
7.2 Asia Pacific Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence Immunoassays (CLIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Immunodiagnostics Market Analysis - Clinical Indication
8.1 Overview
8.2 Asia Pacific Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 COVID-19
8.3.2.1.1 Overview
8.3.2.1.2 COVID-19: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Tuberculosis
8.3.2.2.1 Overview
8.3.2.2.2 Tuberculosis: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Lyme
8.3.2.3.1 Overview
8.3.2.3.2 Lyme: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Infection Management
8.3.2.4.1 Overview
8.3.2.4.2 Infection Management: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Zika
8.3.2.5.1 Overview
8.3.2.5.2 Zika: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.6 Treponema
8.3.2.6.1 Overview
8.3.2.6.2 Treponema: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.7 TORCH
8.3.2.7.1 Overview
8.3.2.7.2 TORCH: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.8 Measles and Mumps
8.3.2.8.1 Overview
8.3.2.8.2 Measles and Mumps: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.9 VZV
8.3.2.9.1 Overview
8.3.2.9.2 VZV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.10 EBV
8.3.2.10.1 Overview
8.3.2.10.2 EBV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
8.6.1 Overview
8.6.2 Metabolics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Immunodiagnostics Market Analysis - End User
9.1 Overview
9.2 Asia Pacific Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Overview
10.1.1.1 China: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3.1 China: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4 China: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4.1 China: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4.2 China: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.5 China: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 Japan: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.3.1 Japan: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4 Japan: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4.1 Japan: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4.2 Japan: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.5 Japan: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 India: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.3.1 India: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4 India: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4.1 India: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4.2 India: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.5 India: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Australia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.3.1 Australia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4 Australia: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4.1 Australia: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4.2 Australia: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.5 Australia: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 South Korea: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.3.1 South Korea: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.4 South Korea: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.4.1 South Korea: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.4.2 South Korea: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.5 South Korea: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.3.1 Rest of Asia Pacific: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.4.1 Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.4.2 Rest of Asia Pacific: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
11. Asia Pacific Immunodiagnostics Market -Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DiaSorin SpA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Danaher Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PerkinElmer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Svar Life Science AB
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. China Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 2. China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 3. China Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 5. China Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. India Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 15. India Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 16. India: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 17. India Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 18. India Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 23. Australia Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Australia Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 28. South Korea: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 29. South Korea Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 30. South Korea Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Asia Pacific Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. Recent Inorganic Growth Strategies in the Asia Pacific immunodiagnostics market
Table 38. Recent Organic Growth Strategies in the Asia Pacific immunodiagnostics market
Table 39. Glossary of Terms, Asia Pacific Immunodiagnostics Market
LIST OF FIGURES
Figure 1. Asia Pacific Immunodiagnostics Market Segmentation
Figure 2. Asia Pacific Immunodiagnostics Market, by Country
Figure 3. Asia Pacific Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Asia Pacific Immunodiagnostics Market
Figure 5. India Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Asia Pacific Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
Figure 10. Asia Pacific Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Chemiluminescence Immunoassays (CLIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vitamin D Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. HIV Detection: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. HIV Ag/Ab Combo Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Other Tests: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Radioimmunoassays (RIA):Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 20. Infectious Diseases: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. COVID-19: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Tuberculosis: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Lyme: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Infection Management: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Zika: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Treponema: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. TORCH: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Measles and Mumps: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 29. VZV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. EBV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Hepatitis+HIV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Gastrointestinal: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Metabolics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Hypertension: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. Growth: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diabetes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Thyroid: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Reproductive Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Asia Pacific Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 42. Hospitals: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 43. Clinics: Asia Pacific Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 44. Diagnostic Laboratories: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 45. Academic and Research Institutes: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 46. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 47. Asia Pacific: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. Asia Pacific: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 49. China: Immunodiagnostics market - Revenue and Forecast to 2030 (US$ Million)
Figure 50. Japan: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. India: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. Australia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. South Korea: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security